Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2017

Mar 15, 2017

32414_dirs_2017-03-14_9fabe12f-5451-48c4-9b01-e52481cbf173.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-03-14

Reporting Person: Donovan Michael Patrick (VP Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-14 Common Stock M 4659 $0.27 Acquired 4659 Direct
2017-03-14 Common Stock M 5000 $2.74 Acquired 9659 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-03-14 Employee Stock Option (right to purchase) $0.27 M 4659 Acquired 2018-01-13 Common Stock (4659) Direct
2017-03-14 Employee Stock Option (right to purchase) $2.74 M 5000 Acquired 2018-12-16 Common Stock (35000) Direct